Mr Musaab YassinCommon Questions

Common Questions · No. 48

A fourth course of antibiotics

When infections keep coming back in a man, the question stops being which antibiotic and becomes why this keeps happening.

By Mr Musaab Yassin, Consultant Urological Surgeon & Andrologist. Oxford and central London.

Urinary tract infections (UTIs) in men deserve a slightly different way of thinking from an isolated episode of uncomplicated cystitis.

When infections keep returning, the clinical question changes. It is no longer only:

“Which antibiotic should treat this episode?”

It becomes:

“Is this definitely recurrent bacterial infection, and why is it happening?”

The evidence base for male UTI is less uniform than many patients—and clinicians—might expect.3 That uncertainty makes culture confirmation, assessment of underlying causes and antibiotic stewardship particularly important.1

What counts as recurrent UTI?

Definitions vary between guidelines, but the general idea is repeated clinically significant urinary infection over a relatively short period.

In men, recurrence is especially important because repeated infection may point to a persistent source or a problem affecting urinary drainage.

Are recurrent urinary symptoms always recurrent infection?

No.

Burning, frequency, urgency, pelvic discomfort and cloudy urine can occur with bacterial infection, but they can also overlap with:

  • chronic prostatitis/chronic pelvic pain syndrome;
  • stones;
  • bladder inflammation;
  • obstruction;
  • urethral narrowing;
  • malignancy;
  • other lower urinary tract disorders.

This is one reason urine culture becomes more valuable when episodes recur. Culture helps answer three questions:

  1. Is significant bacterial growth present?
  2. Is the same organism returning?
  3. Which antibiotics is it sensitive or resistant to?

Repeated symptoms with repeatedly negative cultures should prompt reconsideration of the diagnosis rather than automatic escalation of antibiotics.

Why are UTIs in men different?

Male UTI guidance is surprisingly inconsistent internationally.

A 2022 systematic review identified 29 updated guidelines for male UTI; only 14 were rated as having high methodological quality.3 The review found substantial disagreement over classification and duration of treatment, especially for afebrile infections.3

That lack of consensus reflects limited direct trial evidence in men.

One important distinction is whether there may be prostatic involvement. Bacteria can persist in prostate tissue and contribute to recurrent infection, which changes antibiotic choice and duration.

What can cause recurrent UTI in a man?

Potential contributors include:

  • incomplete bladder emptying;
  • benign prostate obstruction;
  • chronic bacterial prostatitis;
  • urinary stones;
  • urethral stricture;
  • bladder diverticula;
  • urinary catheters;
  • previous instrumentation;
  • structural abnormalities;
  • neurological bladder dysfunction.

Not every man needs investigation for every one of these. The pattern of cultures, symptoms, age and examination helps determine what is sensible.

Why not just treat each episode with antibiotics?

Sometimes that is exactly what the current episode requires.

The concern is not that antibiotics are inappropriate. The concern is repeated empirical treatment without diagnostic review.

Modern European urological infection guidelines place strong emphasis on antimicrobial stewardship: confirming infection where possible, selecting an appropriate drug and duration, and reducing unnecessary antibiotic exposure.1

Repeated or poorly targeted antibiotics can:

  • select resistant bacteria;
  • cause adverse effects;
  • alter the microbiome;
  • obscure whether symptoms are actually infection-related;
  • postpone investigation of an underlying cause.

Could repeated “UTI treatment” delay another diagnosis?

Observational evidence suggests this can happen, although the relationship must be interpreted cautiously.

A 2024 nationwide population-based study examined 29,921 patients with bladder cancer and 149,467 matched reference subjects.2 Among men later diagnosed with bladder cancer, having at least one previous UTI-related treatment was associated with a higher likelihood of more advanced disease at diagnosis (odds ratio 1.28, 95% CI 1.19–1.37).2

The association became stronger as the number of UTI treatments increased.2

This does not prove that antibiotics caused the delay. Several explanations are possible. Symptoms from an undiagnosed bladder tumour may initially have been attributed to infection; patients receiving repeated treatment may also differ in other ways.

The useful clinical lesson is more modest: recurrent or atypical “UTI” symptoms should not indefinitely bypass diagnostic reassessment.

What does UK guidance say about referring men?

Plainly, and it is not widely acted on.

The NICE quality standard on urinary tract infections states that men with recurrent urinary tract infection should be referred for specialist advice. Its rationale is blunt about why: repeated prescribing without identifying a cause "risks missing alternative conditions that may be causing the symptoms such as bladder cancer", as well as driving antibiotic resistance.

So a man on his third or fourth course of antibiotics is not being difficult by asking for an assessment. He is asking for the thing the guidance already recommends.

What investigations might be considered?

Depending on the pattern, assessment may include:

  • review of previous cultures;
  • urine culture during symptoms;
  • examination;
  • ultrasound;
  • measurement of post-void residual urine;
  • assessment for prostate involvement;
  • imaging for stones;
  • cystoscopy in selected men;
  • other targeted tests when anatomy or bladder function is in question.

A 2024 guideline-linked review concluded that urine culture and ultrasonography are reasonable steps in recurrent UTI and noted that further invasive testing is more often suggested in men than in women.4

Does every man with recurrent UTI need cystoscopy?

No.

Cystoscopy should answer a clinical question rather than simply be performed because an infection has happened twice.

It becomes more relevant when there are features such as:

  • visible or persistent non-visible blood in the urine;
  • unexplained recurrent infection;
  • suspected bladder pathology;
  • suspected urethral narrowing;
  • abnormal imaging;
  • significant risk factors.

The principle is targeted investigation, not maximal investigation.

Does every recurrent UTI need a long antibiotic course?

No.

Duration depends on the nature of the infection and whether there is evidence of systemic or prostatic involvement. The systematic review of male-UTI guidelines found substantial international variation, illustrating why a universal duration should not be presented as settled science.3

A febrile infection with suspected prostate involvement is a different clinical problem from an afebrile lower UTI.

Culture results, tissue penetration of the drug, renal function and local resistance patterns matter.

What about antibiotic prevention?

Preventive antibiotics can reduce recurrent UTI in some populations, but the evidence for recurrent UTI prevention is dominated by studies in women. It should therefore not be transferred uncritically to men.4

Before long-term prophylaxis is considered, clinicians generally need confidence that:

  • the episodes are genuine bacterial infections;
  • modifiable causes have been considered;
  • the likely benefits outweigh resistance and side-effect risks.

What symptoms should prompt urgent assessment?

Seek urgent care for:

  • fever with rigors;
  • severe flank or back pain;
  • vomiting or severe systemic illness;
  • inability to pass urine;
  • confusion or signs of sepsis;
  • significant visible haematuria;
  • rapidly worsening symptoms.

A febrile UTI in a man can involve the kidney or prostate and may require a different treatment approach from simple cystitis.

How strong is the evidence?

The 2024 EAU guideline is a broad evidence-based guideline covering urological infections, but not all male recurrent-UTI questions have high-quality trial data.1

The bladder-cancer study is large and population-based, but observational, so it demonstrates association rather than causation.2

The 2022 systematic review of 29 male-UTI guidelines is particularly important because it shows just how much international disagreement remains.3

The recurrent-UTI review supports culture and ultrasound, but much prevention evidence comes from female populations.4

Bottom line

A fourth course of antibiotics may be exactly what is needed if there is a fourth confirmed bacterial infection. But recurrent infection in a man should eventually trigger a second question: why is the infection returning?

Culture confirmation, assessment of urinary emptying, consideration of the prostate and stones, and selective imaging or cystoscopy can prevent repeated symptoms from becoming an endless cycle of empirical treatment.1, 4

The science is not perfect. That is precisely why careful diagnosis matters.

If you are on your third or fourth course of antibiotics for the same problem, the treatment is not the thing that needs changing — the question is. I want to know whether your bladder empties, whether your prostate is involved, whether there is a stone, and whether the last three episodes were even confirmed on culture. That is a single appointment, and it usually ends a cycle that has been running for years.

If this sounds like you

A first consultation is £295, and follow-up £190. It usually runs at least twenty minutes; allow up to an hour if you are likely to need a flow test, scan, or blood or urine test on the day. You do not need a referral to book privately, and you are under no obligation to proceed with anything.

Send an enquiry · Symptom questionnaire · Compare the treatments, with the evidence

The 4 studies behind this page▾
  1. Kranz J, Bartoletti R, Bruyère F, et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. European Urology. 2024. doi:10.1016/j.eururo.2024.03.035
  2. Liedberg F, Gårdmark T, Hagberg O, et al. Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study. European Urology Oncology. 2024. 29,921 bladder-cancer patients; 149,467 matched controls. doi:10.1016/j.euo.2024.07.008
  3. Soudais B, Ribeaucoup F, Schuers M. Guidelines for the management of male urinary tract infections in primary care: a lack of international consensus—a systematic review of the literature. Family Practice. 2022. 29 guidelines. doi:10.1093/fampra/cmac068
  4. Schmiemann G, Kranz J, Mandraka F, et al. The Diagnosis, Treatment, and Prevention of Recurrent Urinary Tract Infection. Deutsches Ärzteblatt International. 2024. doi:10.3238/arztebl.m2024.0068

Mr Musaab Yassin is a Consultant Urological Surgeon and Andrologist practising in Oxford and central London. FRCS (Urol). GMC 6118378. Reviewed August 2026.

This page gives general information and does not replace an individual assessment. Figures quoted come from published research and describe groups of patients rather than any one person — your own history, anatomy and priorities change what they mean for you.